Cargando…

Pharmacological options for pain control in patients with vertebral fragility fractures

This review considers the evidence base and current knowledge for pharmacological treatment options that are available for pain control in patients with vertebral fractures sustained after a low trauma incident. Due care needs to be taken when considering prescribed options for pain control. The dec...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanna, Nuttan Kantilal, Ong, Terence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society of Osteoporosis 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577215/
https://www.ncbi.nlm.nih.gov/pubmed/36268497
http://dx.doi.org/10.1016/j.afos.2022.09.003
_version_ 1784811709450420224
author Tanna, Nuttan Kantilal
Ong, Terence
author_facet Tanna, Nuttan Kantilal
Ong, Terence
author_sort Tanna, Nuttan Kantilal
collection PubMed
description This review considers the evidence base and current knowledge for pharmacological treatment options that are available for pain control in patients with vertebral fractures sustained after a low trauma incident. Due care needs to be taken when considering prescribed options for pain control. The decision should be based on first establishing whether the presentation is one of acute severe pain at the time of a new vertebral fragility fracture incident or whether the complaint is one of the debilitating, longer term chronic back pain syndrome, accompanied by a clinical suspicion of a possible new fracture. The article also presents currently debated questions in this important area of clinical and patient care and will be of interest to the readership worldwide.
format Online
Article
Text
id pubmed-9577215
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Korean Society of Osteoporosis
record_format MEDLINE/PubMed
spelling pubmed-95772152022-10-19 Pharmacological options for pain control in patients with vertebral fragility fractures Tanna, Nuttan Kantilal Ong, Terence Osteoporos Sarcopenia Review Article This review considers the evidence base and current knowledge for pharmacological treatment options that are available for pain control in patients with vertebral fractures sustained after a low trauma incident. Due care needs to be taken when considering prescribed options for pain control. The decision should be based on first establishing whether the presentation is one of acute severe pain at the time of a new vertebral fragility fracture incident or whether the complaint is one of the debilitating, longer term chronic back pain syndrome, accompanied by a clinical suspicion of a possible new fracture. The article also presents currently debated questions in this important area of clinical and patient care and will be of interest to the readership worldwide. Korean Society of Osteoporosis 2022-09 2022-10-03 /pmc/articles/PMC9577215/ /pubmed/36268497 http://dx.doi.org/10.1016/j.afos.2022.09.003 Text en © 2022 The Korean Society of Osteoporosis. Publishing services by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Review Article
Tanna, Nuttan Kantilal
Ong, Terence
Pharmacological options for pain control in patients with vertebral fragility fractures
title Pharmacological options for pain control in patients with vertebral fragility fractures
title_full Pharmacological options for pain control in patients with vertebral fragility fractures
title_fullStr Pharmacological options for pain control in patients with vertebral fragility fractures
title_full_unstemmed Pharmacological options for pain control in patients with vertebral fragility fractures
title_short Pharmacological options for pain control in patients with vertebral fragility fractures
title_sort pharmacological options for pain control in patients with vertebral fragility fractures
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9577215/
https://www.ncbi.nlm.nih.gov/pubmed/36268497
http://dx.doi.org/10.1016/j.afos.2022.09.003
work_keys_str_mv AT tannanuttankantilal pharmacologicaloptionsforpaincontrolinpatientswithvertebralfragilityfractures
AT ongterence pharmacologicaloptionsforpaincontrolinpatientswithvertebralfragilityfractures